Research Article

Dosimetric Comparison of Lung-Sparing Radiation Therapy between Volumetric Arc Therapy and Helical Tomotherapy for Unresectable Malignant Pleural Mesothelioma

Table 2

Dose volume parameters for planning target volumes and organs at risk.

CharacteristicsVMAT median (range)HT median (range) value

PTV45, Gy
Dmax53.9 (52.2–59.2)48.4 (47.1–49.8)0.001
Dmin38.8 (30.7–43.3)37.5 (19.4–43.7)0.81
Dmean49.2 (48.1–52.1)45.8 (45.6–46.1)<0.001

PTV54, Gy
Dmax64.3 (61.9–69.9)57.8 (56.2–59.2)<0.001
Dmin46.8 (37.2–52.1)45.4 (26.7–51.7)0.65
Dmean58.6 (56.3–61.9)55.0 (54.7–55.2)0.001

Ipsilateral lung
 Mean dose, Gy38.2 (20.8–51.4)33.5 (18.0–40.1)0.007
 V5 (%)100 (96.2–100)99.7 (98.0–100)0.59
 V10 (%)100 (77.2–100)95.1 (68.2–100)0.028
 V20 (%)92.0 (43.6–100)80.2 (41.2–100)0.10

Contralateral lung
 Mean dose, Gy11.8 (5.2–18.1)6.7 (5.3–8.1)0.018
 V5 (%)67.8 (33.2–90.0)30.6 (21.4–49.0)0.001
 V10 (%)51.4 (3.9–100)29.6 (11.9–49.0)0.009
 V20 (%)3.5 (0–55.0)0.5 (0–14.3)0.002

Total lung
 Mean dose, Gy19.8 (17.8–33.0)16.1 (10.5–24.4)0.003
 V20 (%)36.2 (25–69.0)29.3 (13.08–45.5)0.021

Spinal cord, Gy
Dmax39.3 (31.9–44.2)33.2 (22.5–34.2)0.005

Heart
 Mean dose, Gy33.3 (12.1–54.9)25.8 (7.3–45.7)0.006
 V25 (%)57.9.0 (7.21–100)43.5 (4.1–95.3)0.002
 V30 (%)50.9 (4.45–100)34.8 (1.4–88.9)0.001

Mean kidney dose, Gy
 Ipsilateral2.5 (1.3–11.2)1.6 (0.7–6.4)0.28
 Contralateral1.9 (0.3–8.9)2.0 (0.2–5.2)0.27

Liver
 Mean dose, Gy13.1 (6.3–33.6)15.1 (8.3–31.4)0.31
 V30 (%)11.0 (0.0–59.2)13.3 (0–50.8)0.67

Esophagus
 Dmean38.6 (16.2–57.8)29.9 (8.3–44.2)0.001
 V3557.2 (0.9–100)42.3 (0–100)0.017
 V5040.3 (0–98.9)29.6 (0–97)0.024

Dosimetric indices
 Conformity index0.96 (0.93–0.99)0.98 (0.97–0.99)0.74
 Homogeneity index1.1 (1.1–1.1)1.036 (1.03–1.05)<0.001

Treatment duration
 Monitor units, per fr529 (471–765)6590 (6185–7116)<0.001
 Treatment time (min/fr)2.5 (2.1–3.0)7.4 (6.9–7.8)<0.001

PTV: planning target volume; VX: volume receiving X Gy; Dmax: maximum dose; Dmin: minimum dose; Dmean: mean dose; fr: fraction.